These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


166 related items for PubMed ID: 10079116

  • 1. Oxidation of methionine residues in coagulation factor VIIa.
    Kornfelt T, Persson E, Palm L.
    Arch Biochem Biophys; 1999 Mar 01; 363(1):43-54. PubMed ID: 10079116
    [Abstract] [Full Text] [Related]

  • 2. In vitro methionine oxidation of Escherichia coli-derived human stem cell factor: effects on the molecular structure, biological activity, and dimerization.
    Hsu YR, Narhi LO, Spahr C, Langley KE, Lu HS.
    Protein Sci; 1996 Jun 01; 5(6):1165-73. PubMed ID: 8762148
    [Abstract] [Full Text] [Related]

  • 3. Products of Cu(II)-catalyzed oxidation of alpha-synuclein fragments containing M1-D2 and H50 residues in the presence of hydrogen peroxide.
    Kowalik-Jankowska T, Rajewska A, Jankowska E, Grzonka Z.
    Dalton Trans; 2008 Feb 14; (6):832-8. PubMed ID: 18239841
    [Abstract] [Full Text] [Related]

  • 4. Products of Cu(II)-catalyzed oxidation of the N-terminal fragments of alpha-synuclein in the presence of hydrogen peroxide.
    Kowalik-Jankowska T, Rajewska A, Jankowska E, Wiśniewska K, Grzonka Z.
    J Inorg Biochem; 2006 Oct 14; 100(10):1623-31. PubMed ID: 16839607
    [Abstract] [Full Text] [Related]

  • 5. Ca2+ in the first epidermal growth factor-like domain of activated factor VII.
    Persson E, Nielsen LS.
    Blood Coagul Fibrinolysis; 1998 Mar 14; 9 Suppl 1():S79-81. PubMed ID: 9819033
    [Abstract] [Full Text] [Related]

  • 6. The use of t-butyl hydroperoxide as a probe for methionine oxidation in proteins.
    Keck RG.
    Anal Biochem; 1996 Apr 05; 236(1):56-62. PubMed ID: 8619496
    [Abstract] [Full Text] [Related]

  • 7. Sequential coagulation factor VIIa domain binding to tissue factor.
    Osterlund M, Persson E, Carlsson U, Freskgård PO, Svensson M.
    Biochem Biophys Res Commun; 2005 Dec 02; 337(4):1276-82. PubMed ID: 16236263
    [Abstract] [Full Text] [Related]

  • 8. Prevention of beta strand movement into a zymogen-like position does not confer higher activity to coagulation factor VIIa.
    Olsen OH, Nielsen PF, Persson E.
    Biochemistry; 2004 Nov 09; 43(44):14096-103. PubMed ID: 15518559
    [Abstract] [Full Text] [Related]

  • 9. Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
    Persson E, Olsen OH.
    FEBS J; 2009 Jun 09; 276(11):3099-109. PubMed ID: 19490111
    [Abstract] [Full Text] [Related]

  • 10. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF, Yang J, Eigenbrot C, Moran P, Peek M, Lipari MT, Kirchhofer D.
    Biochemistry; 2004 Feb 10; 43(5):1223-9. PubMed ID: 14756558
    [Abstract] [Full Text] [Related]

  • 11. A structural and mechanistic study of the oxidation of methionine residues in hPTH(1-34) via experiments and simulations.
    Chu JW, Yin J, Wang DI, Trout BL.
    Biochemistry; 2004 Nov 09; 43(44):14139-48. PubMed ID: 15518564
    [Abstract] [Full Text] [Related]

  • 12. Methionine sulfoxidation of the chloroplast small heat shock protein and conformational changes in the oligomer.
    Gustavsson N, Härndahl U, Emanuelsson A, Roepstorff P, Sundby C.
    Protein Sci; 1999 Nov 09; 8(11):2506-12. PubMed ID: 10595556
    [Abstract] [Full Text] [Related]

  • 13. Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study.
    Petersen LC, Nørby PL, Branner S, Sørensen BB, Elm T, Stennicke HR, Persson E, Bjørn SE.
    Thromb Res; 2005 Nov 09; 116(1):75-85. PubMed ID: 15850611
    [Abstract] [Full Text] [Related]

  • 14. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV, Petrovan RJ, Ruf W, Olson AJ.
    Proteins; 2003 Nov 15; 53(3):640-8. PubMed ID: 14579355
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Substitution of aspartic acid for methionine-306 in factor VIIa abolishes the allosteric linkage between the active site and the binding interface with tissue factor.
    Persson E, Nielsen LS, Olsen OH.
    Biochemistry; 2001 Mar 20; 40(11):3251-6. PubMed ID: 11258943
    [Abstract] [Full Text] [Related]

  • 17. Tissue factor alters the pK(a) values of catalytically important factor VIIa residues.
    Neuenschwander PF, Vernon JT, Morrissey JH.
    Biochemistry; 2002 Mar 12; 41(10):3364-71. PubMed ID: 11876644
    [Abstract] [Full Text] [Related]

  • 18. Rapid determination of oxidized methionine residues in recombinant human basic fibroblast growth factor by ultra-performance liquid chromatography and electrospray ionization quadrupole time-of-flight mass spectrometry with in-source collision-induced dissociation.
    Ohkubo T, Inagaki S, Min JZ, Kamiya D, Toyo'oka T.
    Rapid Commun Mass Spectrom; 2009 Jul 12; 23(13):2053-60. PubMed ID: 19504477
    [Abstract] [Full Text] [Related]

  • 19. Importance of substrate composition, pH and other variables on tissue factor enhancement of factor VIIa activity.
    Neuenschwander PF, Branam DE, Morrissey JH.
    Thromb Haemost; 1993 Dec 20; 70(6):970-7. PubMed ID: 8165620
    [Abstract] [Full Text] [Related]

  • 20. Disulfide locked variants of factor VIIa with a restricted beta-strand conformation have enhanced enzymatic activity.
    Maun HR, Eigenbrot C, Raab H, Arnott D, Phu L, Bullens S, Lazarus RA.
    Protein Sci; 2005 May 20; 14(5):1171-80. PubMed ID: 15840825
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.